Seattle Children’s collaboration to dive into cell therapy manufacturing; After success in court, Teva found guilty in NY

A cell and gene therapy company is extending its collaboration with Seattle Children’s Hospital to establish manufacturing practices for cell therapy, the company announced Tuesday.

BioLife’s new lentiviral vector manufacturing site, dubbed VectorWorks, will be used to find best practices in biopreservation and closed-system manufacturing with the introduction and integration...

Click to view original post